{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T02:34:04Z","timestamp":1768012444011,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.brachy.2021.02.002","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T04:43:04Z","timestamp":1619152984000},"page":"866-872","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Reduction of toxicity in brachytherapy using a new technique"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6085-9771","authenticated-orcid":false,"given":"Yuji","family":"Miyazaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiho","family":"Takenaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutaka","family":"Noda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0238-2690","authenticated-orcid":false,"given":"Nobuyuki","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9101-1749","authenticated-orcid":false,"given":"Takahito","family":"Wakamiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuo","family":"Sonomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2021.02.002_bib1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0167-8140(00)00288-7","article-title":"The role of external beam radiotherapy with I-125\/Pd-103 brachytherapy for prostate carcinoma","volume":"57","author":"Blasko","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2021.02.002_bib2","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1097\/01.ju.0000154633.73092.8e","article-title":"12-Year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer","volume":"173","author":"Potters","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.brachy.2021.02.002_bib3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ijrobp.2008.04.038","article-title":"Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy","volume":"73","author":"Stone","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2021.02.002_bib4","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ijrobp.2011.07.033","article-title":"Predictors of metastatic disease after prostate brachytherapy","volume":"83","author":"Forsythe","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2021.02.002_bib5","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.3390\/cancers3033585","article-title":"Efficacy and safety of high-dose-rate brachytherapy of single implant with two fractions combined with external beam radiotherapy for hormone-na\u00efve localized prostate cancer","volume":"3","author":"Noda","year":"2011","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.brachy.2021.02.002_bib6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.brachy.2013.11.002","article-title":"The 15-year outcomes of high-dose-rate brachytherapy for radical dose escalation in patients with prostate cancer - a benchmark for high-tech external beam radiotherapy alone?","volume":"13","author":"Galalae","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2021.02.002_bib7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.urology.2012.08.062","article-title":"Contemporary urethral stricture characteristics in the developed world","volume":"81","author":"Palminteri","year":"2013","journal-title":"Urology"},{"key":"10.1016\/j.brachy.2021.02.002_bib8","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.radonc.2008.11.013","article-title":"Urethral stricture following high dose rate brachytherapy for prostate cancer","volume":"91","author":"Sullivan","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2021.02.002_bib9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijrobp.2008.11.006","article-title":"Genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external beam radiotherapy for localized prostate cancer: an analysis to determine the correlation between dose-volume histogram parameters in HDR brachytherapy","volume":"75","author":"Ishiyama","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2021.02.002_bib10","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ijrobp.2010.10.009","article-title":"Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer","volume":"82","author":"Mohammed","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2021.02.002_bib11","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.ijrobp.2010.09.006","article-title":"High-dose-rate brachytherapy as a monotherapy for favorable-risk prostate cancer: a phase II trial","volume":"82","author":"Barkati","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2021.02.002_bib12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/COC.0b013e3181b9cd2f","article-title":"High-dose-rate prostate brachytherapy: an excellent accelerated-hypofractionated treatment for favorable prostate cancer","volume":"33","author":"Martinez","year":"2010","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.brachy.2021.02.002_bib13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.brachy.2012.03.004","article-title":"Urethral strictures following high-dose-rate brachytherapy for prostate cancer: analysis of risk factors","volume":"12","author":"Hindson","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2021.02.002_bib14","first-page":"621","article-title":"Clinical outcome in prostate cancer patients undergoing high-dose-rate brachytherapy with external beam radiotherapy in our institute","volume":"102","author":"Sakamoto","year":"2011","journal-title":"Nihon Hinyokika Gakkai Zasshi"},{"key":"10.1016\/j.brachy.2021.02.002_bib15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.radonc.2013.05.002","article-title":"GEC\/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: an update","volume":"107","author":"Hoskin","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2021.02.002_bib16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.prro.2013.02.011","article-title":"A dosimetric anaylsis of radiation therapy Oncology group (RTOG) 0321: the importance of urethral dose","volume":"4","author":"Hsu","year":"2014","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.brachy.2021.02.002_bib17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1464-410X.1983.tb07079.x","article-title":"Post-catheterisation urethral strictures. A clinical and experimental study","volume":"55","author":"Edwards","year":"1983","journal-title":"BJU Int"},{"key":"10.1016\/j.brachy.2021.02.002_bib18","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.brachy.2019.12.001","article-title":"A dosimetric evaluation of a single urethral constraint for high-dose-rate prostate brachytherapy","volume":"19","author":"Lu","year":"2020","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2021.02.002_bib19","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.crad.2015.06.093","article-title":"PI-RADS version 2: what you need to know","volume":"70","author":"Barrett","year":"2015","journal-title":"Clin Radiol"},{"key":"10.1016\/j.brachy.2021.02.002_bib21","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.brachy.2021.02.002_bib22","first-page":"131","article-title":"A survey of exact inference for contingency tables","volume":"7","author":"Alan","year":"1992","journal-title":"Stat Sci"},{"key":"10.1016\/j.brachy.2021.02.002_bib23","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0360-3016(02)02897-3","article-title":"Early clinical experience with anatomy-based inverse planning dose optimization for high-dose-rate boost of the prostate","volume":"54","author":"Lachance","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2021.02.002_bib24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.brachy.2004.05.007","article-title":"Comparison of inverse planning simulated annealing and geometrical optimization for prostate high-dose-rate brachytherapy","volume":"3","author":"Hsu","year":"2004","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2021.02.002_bib25","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.radonc.2005.04.002","article-title":"Anatomy-based inverse planning dose optimization in HDR prostate implant: a toxicity study","volume":"75","author":"Mahmoudieh","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2021.02.002_bib26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.brachy.2007.10.001","article-title":"A comparison of anatomy-based inverse planning with simulated annealing and graphical optimization for high-dose-rate prostate brachytherapy","volume":"7","author":"Morton","year":"2008","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2021.02.002_bib27","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.ijrobp.2008.12.051","article-title":"Correlation between dosimetric parameters and late rectal and urinary toxicities in patients treated with high-dose-rate brachytherapy used as monotherapy for prostate cancer","volume":"75","author":"Konishi","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2021.02.002_bib28","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ijrobp.2009.05.054","article-title":"Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for men with intermediate-risk prostate cancer: analysis of short- and medium-term toxicity and quality of life","volume":"77","author":"Morton","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2021.02.002_bib29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.brachy.2010.11.007","article-title":"Use of cone-beam imaging to correct for catheter displacement in high dose-rate prostate brachytherapy","volume":"10","author":"Holly","year":"2011","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2021.02.002_bib30","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1046\/j.1469-7580.2003.00181.x","article-title":"Structure of the pelvic and penile urethra - relationship with the ducts of the sex accessory glands of the Mongolian gerbil (Meriones unguiculatus)","volume":"202","author":"Pinheiro","year":"2003","journal-title":"J Anat"},{"key":"10.1016\/j.brachy.2021.02.002_bib31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ijrobp.2012.03.004","article-title":"Meta-analysis of the alpha\/beta ratio for prostate cancer in the presence of an overall time factor: bad news, good news, or no news?","volume":"85","author":"Vogelius","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2021.02.002_bib32","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.ijrobp.2016.12.024","article-title":"Continued benefit to rectal separation for prostate radiation therapy: final results of a phase III trial","volume":"97","author":"Hamstra","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2021.02.002_bib33","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.ijrobp.2015.04.030","article-title":"Hydrogel spacer prospective multicenter randomized controlled pivotal trial: dosimetric and clinical effects of perirectal spacer application in men undergoing prostate image guided intensity modulated radiation therapy","volume":"92","author":"Mariados","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2021.02.002_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-017-0789-9","article-title":"Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy","volume":"12","author":"Mbeutcha","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.brachy.2021.02.002_bib35","first-page":"20","article-title":"Efficacy and toxicity outcomes for patients treated with focal salvage high dose rate brachytherapy for locally recurrent prostate cancer","volume":"23","author":"Slevin","year":"2020","journal-title":"Clin Transl Radiat Oncol"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472121000398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472121000398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:08:53Z","timestamp":1762549733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472121000398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1538472121000398"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2021.02.002","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduction of toxicity in brachytherapy using a new technique","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2021.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}